33๋„ ๋Œ€ 36๋„ ๋ชฉํ‘œ์ฒด์˜จ๊ด€๋ฆฌ / 33 vs 36 targeted temperature management

์ •์˜

33๋„ ๋Œ€ 36๋„ TTM ๋น„๊ต๋Š” ROSC ํ›„ ํ˜ผ์ˆ˜ ํ™˜์ž์—์„œ ๊นŠ์€ ์ €์ฒด์˜จ์„ ์ ์šฉํ• ์ง€, 36๋„ ์ค‘์‹ฌ์˜ ๋ฐœ์—ด ๋ฐฉ์ง€ ์ „๋žต์„ ์ ์šฉํ• ์ง€์— ๋Œ€ํ•œ ์„ ํƒ์ด๋‹ค.

์ž„์ƒ ํ•ต์‹ฌ

Raw note์˜ ๊ฒฐ๋ก ์€ 33โ€“37.5๋„ ์ดํ•˜๋กœ ์œ ์ง€ํ•˜๋ฉด ๋˜๋ฉฐ, ๋ฐœ์—ด ๋ฐฉ์ง€๊ฐ€ ํ•ต์‹ฌ์ด๋ผ๋Š” ๊ฒƒ์ด๋‹ค. 36๋„๋„ ์ •์ƒ ์ฒด์˜จ๋ณด๋‹ค ๋‚ฎ์•„ shivering ์–ต์ œ๋ฅผ ์œ„ํ•œ sedation/NMB๊ฐ€ ํ•„์š”ํ•  ์ˆ˜ ์žˆ๋‹ค. 33๋„๋Š” ๋Œ€์‚ฌ์™€ ์‚ฐ์†Œ ์š”๊ตฌ๋Ÿ‰์„ ๋” ๋‚ฎ์ถœ ์ˆ˜ ์žˆ์ง€๋งŒ bradycardia, hypotension, coagulopathy ์œ„ํ—˜์ด ์ปค์งˆ ์ˆ˜ ์žˆ๋‹ค.

์ง„๋‹จ

33๋„ ์„ ํ˜ธ ์ƒํ™ฉ: shockable rhythm(VF, pulseless VT), vital sign ์•ˆ์ •, ์ Š์€ ํ™˜์ž, seizure ์กฐ์ ˆ, ๋‡Œ๋ถ€์ข… ์กฐ์ ˆ ๋ชฉ์ . 36๋„ ์„ ํ˜ธ ์ƒํ™ฉ: nonshockable rhythm(PEA, asystole), vital sign ๋ถˆ์•ˆ์ •, ๋†’์€ vasopressor ์š”๊ตฌ๋Ÿ‰, sepsis/infection concern. Active bleeding, trauma, massive bleeding, ์ž„์‹ ยท์†Œ์•„, ์ €์ฒด์˜จ ์œ ๋ฐœ ์‹ฌ์ •์ง€ ๊ฐ€๋Šฅ์„ฑ์€ 33๋„ ์ „๋žต์— ๋ถˆ๋ฆฌํ•˜๋‹ค.

์น˜๋ฃŒ

๋‘ ์ „๋žต ๋ชจ๋‘ core temperature monitoring, shivering ์–ต์ œ, seizure ๊ฐ์‹œ, ์„œ์„œํžˆ rewarming์ด ํ•„์š”ํ•˜๋‹ค. Rewarming์€ ์‹œ๊ฐ„๋‹น 0.25โ€“0.5๋„ ์†๋„๋กœ ์‹œํ–‰ํ•˜๋ฉฐ ๋น ๋ฅธ ์žฌ๊ฐ€์˜จ์„ ํ”ผํ•œ๋‹ค. ์ดˆ๊ธฐ ์ฒด์˜จ์ด 32โ€“34๋„๋กœ ๋‚ฎ์œผ๋ฉด ์–ต์ง€๋กœ ๋ชฉํ‘œ ์˜จ๋„๊นŒ์ง€ ์˜ฌ๋ฆด ํ•„์š”๋Š” ์—†๋‹ค๊ณ  ์ •๋ฆฌ๋˜์–ด ์žˆ๋‹ค.

์ถœ์ฒ˜

Raw note cites Bernard NEJM, TTM trial 1, TTM trial 2, but no DOI or guideline identifier is provided.

๐ŸŒฑ ์ถœ์ฒ˜ raw


๋ณธ ๋ฌธ์„œ๋Š” ํ•™์Šตยท์ฐธ๊ณ ์šฉ์ด๋ฉฐ ์‹ค์ œ ์ง„๋ฃŒ ๊ฒฐ์ •์€ ์ž„์ƒ์˜์˜ ํŒ๋‹จ์ž…๋‹ˆ๋‹ค.